Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Total Current Liabilities (2021 - 2025)

Universe Pharmaceuticals (UPC) has disclosed Total Current Liabilities for 5 consecutive years, with $13.2 billion as the latest value for Q3 2025.

  • Quarterly Total Current Liabilities fell 35.15% to $13.2 billion in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $13.2 billion through Sep 2025, down 35.15% year-over-year, with the annual reading at $13.2 billion for FY2025, 35.15% down from the prior year.
  • Total Current Liabilities hit $13.2 billion in Q3 2025 for Universe Pharmaceuticals, down from $20.3 billion in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $20.3 billion in Q3 2024 to a low of $11.2 million in Q3 2021.
  • Historically, Total Current Liabilities has averaged $6.7 billion across 5 years, with a median of $13.8 million in 2023.
  • Biggest five-year swings in Total Current Liabilities: surged 147584.19% in 2024 and later plummeted 35.15% in 2025.
  • Year by year, Total Current Liabilities stood at $11.2 million in 2021, then increased by 16.83% to $13.1 million in 2022, then rose by 5.01% to $13.8 million in 2023, then soared by 147584.19% to $20.3 billion in 2024, then plummeted by 35.15% to $13.2 billion in 2025.
  • Business Quant data shows Total Current Liabilities for UPC at $13.2 billion in Q3 2025, $20.3 billion in Q3 2024, and $13.8 million in Q3 2023.